DSP Clinical President and Founder Darlene Panzitta to Address PHT Corporation 17th PRO & eCOA Congress
CRO executive to discuss how pharmaceutical and device companies can leverage eClinical technologies to collect better data and stay on budget
PARSIPPANY, New Jersey – March 18 – DSP Clinical President and Founder Darlene Panzitta will present at PHT Corporation’s 17th PRO & eCOA Congress, March 26-28, Baltimore. DSP provides customer-focused, results-driven Contract Research Services for Phase I-IV clinical studies for the niche market segment of small to mid-size pharmaceutical, life science, and medical device companies.
Darlene’s presentation, “How ePRO Reduces Monitoring Costs,” will discuss how clinical trial sponsors can use electronic patient reported outcomes (ePRO) devices to reduce and improve budget and monitoring resources.
Darlene Panzitta has worked in the drug development industry for over 17 years and has earned a national reputation for excellence in clinical trial management and monitoring. In 2012, Darlene was named to the PharmaVOICE 100 list of the most influential people in the life sciences industry. She is an expert in early to late stage drug development with a focus on local and global study management. Her therapeutic expertise includes women’s health and reproductive endocrinology with additional experience in endocrinology, urology, pain, CNS, gastrointestinal, dermatology, and devices. Darlene holds a Bachelor of Science degree in Science and a Master of Science degree in Biology from Farleigh Dickinson University.
About DSP Clinical
DSP Clinical is a full service contract research organization that manages Phase I to IV clinical studies for small to mid-size pharmaceutical, biotechnology, and medical device companies. DSP helps clients get drugs to market faster than their competition with its aggressive approach and use of a fixed cost billing model. DSP drives top-tier success for domestic and international clients through unmatched experience, flexibility, passionate leadership, aggressive strategies, and operational excellence. In 2012, DSP was acknowledged as one of the 50 Fastest Growing Women-Owned/Led Companies in North America by the Women President’s Organization (WPO) and American Express OPEN.
DSP services include overall project management, study site management, site monitoring, data management, statistics, medical writing, and FDA submissions management. Visit www.dspclinical.com.
Media contact: Brenda Nashawaty, firstname.lastname@example.org, 617-688-3253